Continuous subcutaneous infusion of recombinant human growth hormone (rhGH) improved renal function in a patient with Sheehan's syndrome associated with chronic renal failure.
Sohmiya
M
M
Department of Medicine, Shimane Medical University, Izumo, Japan. motoi@shimane-med.ac.jp
Nishiki
M
M
Kato
Y
Y
D000368:Aged; D001806:Blood Urea Nitrogen; D003404:Creatinine / Q000097:blood; D005260:Female; D005919:Glomerular Filtration Rate / Q000187:drug effects; D006651:Histocytochemistry; D019382:Human Growth Hormone / Q000097:blood / Q000627:therapeutic use*; D006801:Humans; D007018:Hypopituitarism / Q000150:complications / Q000188:drug therapy* / Q000378:metabolism; D007334:Insulin-Like Growth Factor I / Q000378:metabolism; D007668:Kidney / Q000187:drug effects / Q000473:pathology; D007676:Kidney Failure, Chronic / Q000150:complications / Q000188:drug therapy* / Q000378:metabolism; D019275:Radiopharmaceuticals / Q000097:blood / Q000627:therapeutic use; D011994:Recombinant Proteins / Q000097:blood / Q000627:therapeutic use; D016284:Technetium Tc 99m Pentetate / Q000097:blood
D019275:Radiopharmaceuticals; D011994:Recombinant Proteins; D019382:Human Growth Hormone; D007334:Insulin-Like Growth Factor I; D003404:Creatinine; D016284:Technetium Tc 99m Pentetate